Simon Barry J. — SEC Form 4 filings
SEC reporting owner CIK 1647994. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-26.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-02 to 2026-06-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 5 filings — 450,000 shares, $4,140,899 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 165,000 shares @ $10.25 ($1,691,102) in ImmunityBio, Inc., filed 2026-02-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | Director | 9 | — | 7 legs · 450,000 sh · $4,140,899 | 13 |
| Viracta Therapeutics, Inc. (VIRX) | Director | 1 | — | — | 1 |
Form 4 filings — Simon Barry J.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-26 | 4 | ImmunityBio, Inc. (IBRX) | Sale (S): 25,000 @ $7.88 | EDGAR |
| 2026-06-05 | 4 | ImmunityBio, Inc. (IBRX) | Sale (S): 23,033 @ $7.18 | EDGAR |
| 2026-02-26 | 4 | ImmunityBio, Inc. (IBRX) | Sale (S): 75,000 @ $12.01 | EDGAR |
| 2026-02-24 | 4 | ImmunityBio, Inc. (IBRX) | Sale (S): 10,000 @ $9.25 · Option exercise (M): 15,243 @ $0 · Tax withholding (F): 6,026 @ $8.70 · Sale (S): 165,000 @ $10.25 · Option exercise (M): 15,243 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | ImmunityBio, Inc. (IBRX) | Sale (S): 76,967 @ $6.54 · Sale (S): 75,000 @ $7.88 | EDGAR |
| 2025-02-25 | 4 | ImmunityBio, Inc. (IBRX) | Option exercise (M): 15,243 @ $0 · Tax withholding (F): 5,453 @ $3.42 · Option exercise (M): 15,243 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | ImmunityBio, Inc. (IBRX) | Option exercise (M): 110,020 @ $2.00 · Option exercise (M): 110,020 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Viracta Therapeutics, Inc. (VIRX) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-02-26 | 4 | ImmunityBio, Inc. (IBRX) | Grant/award (A): 45,731 (derivative) @ $0 · Grant/award (A): 159,146 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | ImmunityBio, Inc. (IBRX) | Option exercise (M): 57,200 @ $0 · Tax withholding (F): 22,094 @ $3.36 · Option exercise (M): 57,200 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1647994 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →